Key terms

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MESO news

Yesterday 7:59am ET Mesoblast Director Boosts Stake, Awaits Shares Approval by TipRanks May 02 11:10am ET Biotech Alert: Searches spiking for these stocks today by TipRanks May 01 10:51am ET Biotech Alert: Searches spiking for these stocks today by TipRanks May 01 7:29am ET Mesoblast Nears FDA Approval for Key Therapies by TipRanks Apr 23 8:46am ET Largest borrow rate increases among liquid names by TipRanks Apr 17 6:58am ET Mesoblast Director Boosts Share Ownership by TipRanks Apr 17 6:58am ET Mesoblast Applies for Quotation of New Shares by TipRanks Apr 17 6:58am ET Mesoblast Issues New Employee Incentive Options by TipRanks Apr 17 6:57am ET Mesoblast Reports Cessation of 80,000 Options by TipRanks Apr 15 8:46am ET Largest borrow rate increases among liquid names by TipRanks Apr 12 8:46am ET Largest borrow rate increases among liquid names by TipRanks Mar 28 10:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 21 6:57am ET Mesoblast Limited Announces New Share Issue by TipRanks Mar 14 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 13 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 12 6:36am ET Mesoblast (MESO) Gets a Hold from Piper Sandler by TipRanks Mar 03 7:16am ET Mesoblast Limited (MEOBF) Receives a Buy from Jefferies by TipRanks Feb 29 7:48am ET Mesoblast (MESO) Gets a Hold from Piper Sandler by TipRanks Feb 14 7:50pm ET FDA grants Mesoblast orphan-drug designation for Revascor by TipRanks Feb 14 2:56pm ET Mesoblast treatment of Hypoplastic Left Heart Syndrome gets orphan status by TipRanks

No recent press releases are available for MESO

MESO Financials

1-year income & revenue

Key terms

MESO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MESO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Warren Buffett (L), CEO of Berkshire Hathaway, and Vice Chairman Charlie Munger attend the 2019 annual shareholders meeting in Omaha, Nebraska, May 3, 2019.
Johannes Eisele/AFP/Getty Images
Warren Buffett holds first Berkshire Hathaway meeting without Charlie Munger
People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stocks close higher after softer-than-expected jobs report fuels hopes of an earlier rate cut
People work at a Starbucks in Manhattan on February 02, 2024 in New York City.
Spencer Platt/Getty Images
Restaurants are competing for frugal diners’ dollars
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City.
Michael M. Santiago/Getty Images/File
Sell in May and go away? Think again